NCT00215137 - Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

January 31, 2009

Study Completion Date

March 31, 2009

Conditions

OCD

Interventions

DRUG

escitalopram

Open label Treatment: Escitalopram 10 mg/day for 1 week and then 20 mg /day for 7 weeks. Double Blind Treatment: Escitalopram 20 mg/day.

DRUG

Placebo ( sugar pill)

Placebo Comparator in double.blind phase.

Trial Locations (1)

Duke University Medical Center, Durham